EDISON, N.J., May 6, 2015 /PRNewswire/ — Bone Biologics, Corp., (“Bone Biologics”) announced today the completion of a $2M funding round with Hankey Capital, LLC (“Hankey Capital”) of Los Angeles, CA. The company is developing a proprietary protein for use

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone